Professor, Dr. Anna Rostedt Punga

Professor Anna Rostedt Punga defended her Ph.D. thesis in 2005 on different antibody subtypes of MG in the Department of Neuroscience, Uppsala University, 2007.  Further, her postdoctoral studies in Basel, Switzerland, focusing on animal models of MG, rendered an international award from the German Myasthenia Gravis Foundation (Eberhardt Pfleiderer Prize). In 2014, she started her translational research group on MG at Uppsala University. The research focuses on improving diagnostic and monitoring tools in MG and disorders of disturbed neuromuscular transmission, including biomarkers and neurophysiology, both in-vivo and in-vitro, and novel treatment options. Professor Punga´s team has pioneered the field of microRNA biomarker discovery in MG and electrophysiological biomarkers measuring the effect of botulinum toxin effects in facial muscles. She held/holds multiple highly competitive national research grants and was awarded Göran Gustafsson large prize in medicine for her studies in MG. Professor Punga has published 66 peer-reviewed original articles, 12 review articles, and three book chapters. She was recently invited as a keynote speaker on the theme biomarkers in MG at the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) meeting in Phoenix, Arizona, USA, Nov 1, 2023, and as a plenary speaker at the International Congress on Neuromuscular Disorders (ICNMD) in Perth, Australia, Oct 29, 2024.